logo
What Is The State Of Manufacturing & Supply Chain In 2025?

What Is The State Of Manufacturing & Supply Chain In 2025?

Forbes30-04-2025

Fictiv's 2025 State of Manufacturing & Supply Chain Report
This month, I'm excited to share the results of Fictiv's 10th Annual State of Manufacturing & Supply Chain Report. Every year, we survey hundreds of supply chain and manufacturing leaders across multiple industries to understand their perspectives, challenges, and predictions for 2025. I'm especially excited to dive into the broader supply chain results, particularly in a year marked by massive tariff and trade disruptions.
Our first findings concern business uncertainty. With the shift in the U.S. President's trade policies, almost 100% say they're concerned that trade wars are likely to escalate in the next few years (clearly demonstrated by widespread global tariffs).
Key Findings
96% of manufacturing leaders report they're concerned about the impact of the U.S. President's trade policies.
93% believe trade wars will likely escalate in the next few years, whereas 42% are now 'very concerned' —a 6-point increase over 2024.
91% note that global tensions are being considered in their company's long-term supply chain strategy—a 5-point increase over 2024.
Growing global business uncertainty
Looking at this chart, it's clear senior leaders are concerned about tariffs, particularly the impacts on costs and profitability, as well as global business. As a result, many are planning to increase manufacturing in the U.S.
The next key finding is around accelerating supply chain disruptions. Across the board, executives are saying they need to accelerate how they manage their supply chain. Two-thirds or 68% said that onshoring is a key priority this year for their teams.
Key Findings
68% of leaders prioritize onshoring as a key supply chain strategy in 2025, especially in industries needing complex parts at scale, like MedTech, clean energy, and EVs.
77% report a lack of resources (e.g., workforce, budget) severely limits their ability to manage their supply chains effectively (an increase over 2024).
52% of manufacturing leaders identify supplier quality, reliability, and compliance as significant challenges.
Accelerating supply chain disruptions
On the flip side, three-quarters, or 77%, say they lack the resources to effectively manage their supply chain as it is today. This is difficult given that leaders also say they want to onshore their supply chain. If supply chain resources are already limited, moving back to the U.S. will be a challenge.
50% are also saying that quality and reliability are significant challenges. Some are running well-performing supply chains, while another half are running inadequate supply chains.
Our third major finding is around scaling production. In my opinion, this has been the most difficult it's ever been. What you see here is 91% say they're facing barriers to innovation. In other words, they're struggling to find high-quality supply chain partners to do low-volume builds.
Key Findings
91% of manufacturing and supply chain leaders face barriers to product innovation and introduction, with nearly half struggling to source fast, high-quality solutions for low-volume builds.
86% report sourcing parts and materials takes time away from initiatives like new product innovation and introduction, making it increasingly difficult to move into and scale production.
90% of leaders consistently report that digital manufacturing platforms are an essential service for production (up from 86% in 2024).
Scaling production more difficult than ever
Secondly, almost 90% are saying that all the work required to source parts is taking away from innovation. In other words, you're launching a new product, and sourcing has become the bottleneck, the long pole on the tent. This makes driving innovation to build electric vehicles, rockets, and surgical equipment incredibly difficult—stalling the innovations of tomorrow.
In the 10 years we've been doing this report, we've consistently seen this trend. Executives are looking to digitize supply chains. This continues to be a key focus area and it's even up from the 86% that we saw last year. So my takeaway is that for teams that are scaling new products, and moving into production, you have to think about this as another phase of development. You have development that happens by building prototype one. Getting it in the market is the next and most difficult step.
Key Findings
95% report weather and extreme climate events are impacting their supply chain strategy in 2025.
91% now have sustainability initiatives and governance in place to help drive sustainability goals.
52% believe nearshoring and onshoring strategies are critical to supporting sustainability efforts.
Sustainability takes hold
The fourth finding centers around sustainability. This continues to be a major focus for our audience. As we know at the macro level, we've seen massive fires in California, floods and tsunamis globally, and hurricanes. These weather and extreme climate events are impacting supply chains around the world, and no industry is protected.
It's heartening to see that 91% now have sustainability initiatives and some type of governance in place, an increase from previous years. ESG has been a clear focus area for many executives and supply chain teams. However, this year, with 91% saying they have actual governance in place to do a triple bottom line, that's really encouraging to me. We're seeing sustainability as a large driver and metric for consideration in supply chains.
And lastly, nearshoring and onshoring are critical to supporting sustainability efforts. So nearshoring might not necessarily be a pure climate or sustainability play. There are other factors like economics, and geopolitical factors in play here. We thought this was an interesting takeaway. It's not just about reducing the carbon emissions by being closer to your customer, there are multiple considerations when nearshoring but excited to see this continue to be top of mind in our 10th Annual State of Manufacturing and Supply Chain Report.
And you can't have a report on the state of manufacturing in 2025 without AI. AI is the top trend shaping their long-term strategy, whether it's the latest, greatest LLMs or looking at augmenting human tasks, AI is at the forefront of our customers' minds.
Key Findings
87% of leaders report advanced levels of maturity with their company's AI implementations.
94% use AI for manufacturing and supply chain operations, such as inventory management and product design.
56% of Manufacturing and supply chain leaders identify AI as the leading trend shaping their long-term strategy, with economic headwinds following at 53%.
AI advances
Also, 87% report advanced levels of maturity in implementing AI. Almost 100% say their teams are getting better at using it for day-to-day tasks. I personally use it every single day, and I encourage all of our employees, partners, and customers to look at the ways that AI can help bring efficiencies to their work.
94% are saying that AI for manufacturing and supply chain operations is their main implementation, whether it's inventory management, product design, research, or supplier development. One of the best implementations that I saw was all around SCARS, so Corrective Action Reports and using it to help automate the process of managing supply chains. There are a lot of great applications and agentic products out there, and I would really encourage you to look at this to streamline your operations. If you don't do it, your competition will.
I think that while AI is here and will cause a lot of disruption, I think there are multiple factors to consider. So make sure you're figuring out how to implement it, implement it well, and use it daily, but it's not necessarily the silver bullet to solve all supply chain challenges.
Here are a few useful takeaways from the report for your consideration:
To download the full report, please go here. You can also watch an in-depth webinar discussion with Fictiv's General Managers of China, India, Mexico, and the U.S.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HealthKois Launches USD 300 Mn Healthcare-Focused Fund
HealthKois Launches USD 300 Mn Healthcare-Focused Fund

Entrepreneur

time3 days ago

  • Entrepreneur

HealthKois Launches USD 300 Mn Healthcare-Focused Fund

Over the next four years, the firm aims to invest between USD 7 million to USD 25 million per company in early growth-stage businesses operating across healthtech, life sciences, medtech, healthcare delivery and climate health. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. In a major boost to India's healthcare investment landscape, HealthKois, a new healthcare-focused investment firm, has been launched with a target corpus of USD 300 million and an additional USD 100 million green shoe option. Spearheaded by the leadership team behind HealthQuad—Charles Janssen (Managing Partner), Ajay Mahipal (Partner), and Dr Pinak Shrikhande (Partner)—the firm aims to accelerate healthcare transformation through strategic investments in high-impact, technology-driven enterprises. As the successor fund to HealthQuad, HealthKois is set to invest between USD 7 million and USD 25 million per company over the next four years. The focus will be on early growth-stage businesses across healthtech, life sciences, medtech, healthcare delivery, and climate health sectors. The goal is to support ventures that deliver both robust clinical outcomes and sustainable infrastructure solutions. "HealthKois will back technology-led and innovative healthcare companies that address critical gaps in accessibility, affordability, and quality of care," said Charles Janssen. "With access to over 75% proprietary deal flow, we're well-positioned to leverage our deep networks and operational expertise to deliver both superior financial returns and societal outcomes." "HealthKois represents our deep belief that meaningful change in healthcare can only be achieved by scaling enterprises that blend purpose with performance," said Ajay Mahipal. "We're not just capital providers—we're long-term collaborators with founders, bringing strategic insight and sector knowledge to help unlock their full potential." Dr Pinak Shrikhande added, "Our experience has taught us that true innovation in healthcare is born out of empathy, evidence, and execution. We look for companies that go beyond intent to deliver real clinical and operational impact." HealthKois builds on the legacy of HealthQuad Funds I and II, which have collectively touched over 90 million lives and serve more than 8 million patients annually. While the earlier funds will continue under their current framework, HealthKois signals a new chapter in advancing healthcare innovation across India and other low- and middle-income countries.

MEDevice Boston Unveils Expanded Features for 2025 Event
MEDevice Boston Unveils Expanded Features for 2025 Event

Yahoo

time3 days ago

  • Yahoo

MEDevice Boston Unveils Expanded Features for 2025 Event

BOSTON, MA / / June 5, 2025 / MEDevice Boston, the premier event for medical device professionals in New England (September 30-October 1 at the Boston Convention Center, Boston), announces an extensive lineup of new features for its upcoming conference and exhibition. Under the theme "Engineered to Advance," the event will deliver curated insights, strategic connections and meaningful opportunities specifically designed to propel careers and businesses forward at the heart of New England's MedTech hub. The revamped slate is centered on enhancing engagement and intentional opportunities for meaningful interaction. From peer-to-peer learning spaces to dynamic networking formats, every addition is crafted to maximize value, spark innovation and create lasting relationships within the MedTech community, particularly in Boston, which leads the nation in aggregate employment with more than 40,000 professionals and stands as one of its most vibrant innovation ecosystems. New Show Floor Features Include: Enhanced Conference Program: Expert-led sessions designed to tackle today's key challenges and opportunities in MedTech. Hands-On Workshops: Interactive sessions where MedTech professionals can turn ideas into action under expert guidance. Quick-Connect: High-energy, time-efficient networking designed to spark meaningful connections in minutes. Expanded Networking Opportunities: Daily roundtable discussions, themed show floor tours and welcome receptions. Innovation Center: A dedicated space to experience the latest innovations through live device simulations and hands-on exploration. Fireside Chats: A candid forum where MedTech leaders share real stories, bold insights and future-focused ideas. Innovation Spotlight Theater: Live, dynamic presentations from suppliers showcasing cutting-edge technology. Leaders in MedTech Program: Exclusive opportunities to connect with peers from startups to the top 40 OEMs in the New England region. The Franklin Visionary Awards Luncheon: Prestigious recognition for breakthrough technologies combined with high-level networking. "Medical device professionals cannot afford to waste time," says Melissa Magestro, Vice President, Informa Markets Engineering. "They are looking for solutions to their specific needs so they can advance themselves, their businesses, the industry and ultimately, patient care worldwide. We have engineered our entire event experience specifically to advance the medical device industry and the people and businesses that serve it." With the expanded features and renewed focus on valuable engagement, MEDevice Boston remains a trusted touchpoint for staying ahead of the curve. Whether attendees are seeking insight into emerging technologies, strategic guidance or a space to showcase advancements, the 2025 edition promises to deliver tangible value and fresh perspective in a constantly shifting MedTech landscape. Registration for MEDevice Boston 2025 is now open, please visit: About Informa Markets Engineering Informa Markets Engineering, a subsidiary of Informa plc (LON:INF), portfolio is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa, the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit Media Contact Informa Markets EngineeringEngineeringPR@ SOURCE: INFORMA MARKETS - ENGINEERING View the original press release on ACCESS Newswire

SetPoint Medical Appoints Tyler Binney to Its Board of Directors
SetPoint Medical Appoints Tyler Binney to Its Board of Directors

Yahoo

time5 days ago

  • Yahoo

SetPoint Medical Appoints Tyler Binney to Its Board of Directors

VALENCIA, Calif., June 04, 2025--(BUSINESS WIRE)--SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today announced the appointment of Tyler Binney to its Board of Directors. With a career built around scaling disruptive MedTech platforms, Binney brings over two decades of commercial leadership experience that will be instrumental to SetPoint's mission to deliver a new treatment alternative to patients with autoimmune conditions, including rheumatoid arthritis (RA). "Tyler has a strong track record of building successful commercial organizations and delivering sustained growth in new markets," said Murthy V. Simhambhatla, Ph.D., Chief Executive Officer of SetPoint Medical. "His experience bringing novel, category-creating technologies to market will be an incredible asset to our team as we work to provide patients with access to our innovative neuroimmune modulation platform." With over 20 years of proven leadership experience in the medical device industry, Mr. Binney most recently served as President and Chief Executive Officer of Relievant Medical Systems, which Boston Scientific acquired in November 2023 for an upfront payment of $850 million, plus performance-based earnouts. Previously, he served as President and General Manager of the Interventional Urology Business Unit at Teleflex, and as Vice President of Sales at NeoTract, where he led the successful commercialization of the UroLift® System, contributing to its $1.1 billion acquisition by Teleflex. "What SetPoint is doing in the field of neuroimmune modulation is truly groundbreaking," said Tyler Binney. "This team is on the verge of transforming the treatment of chronic autoimmune conditions, and I look forward to contributing my experience as they accelerate their strategy to commercialize this platform technology." About SetPoint Medical SetPoint Medical is a privately held clinical-stage healthcare company dedicated to treating people living with chronic autoimmune diseases. The company is developing a novel platform designed to stimulate the vagus nerve to activate neuroimmune pathways to produce a systemic anti-inflammatory and immune-restorative effect. SetPoint Medical's platform technology is designed to offer patients and providers a treatment alternative for rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy. For more information, visit View source version on Contacts Emma YangHealth+Commercemedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store